Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.





Inbox: RCB erhöht Mayr-Melnhof-Kursziel


Mayr-Melnhof
Akt. Indikation:  86.30 / 87.20
Uhrzeit:  13:04:47
Veränderung zu letztem SK:  0.29%
Letzter SK:  86.50 ( 1.88%)

22.08.2017

Zugemailt von / gefunden bei: RCB (BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

Mayr-Melnhof confirmed at BUY, TP EUR 123 - Cartonboard margin recovery confirmed

- We maintain the BUY recommendation for Mayr-Melnhof on the back of a slight target price increase to EUR 123 from EUR 119
- 2Q results were no catalyst, but we identify two positive take-aways: 1) The EBIT margin in the MM Karton division recouped the 7% threshold thanks to higher selling prices and 2) the company gave a more confident outlook, pointing towards a broad-based strengthening of order behaviour in its main European markets
- In the short run we regard a potential M&A transaction (pharma packaging) as the main catalyst for the share price
- We have tweaked our EBIT estimate for the current year to EUR 213 mn (flat yoy) from EUR 216 mn whereas 2018-19e operating profit estimates of EUR 224 mn and EUR 233 mn, respectively, have remained unchanged.

We maintain the BUY recommendation for Mayr-Melnhof on the back of a slight target price increase to EUR 123 from EUR 119. 2Q results were no catalyst, with operating profit and EPS marginally shy of expectations, but we identify two positive take-aways. Firstly, the EBIT margin in the MM Karton division recouped the 7% threshold from 5.6% in 4Q and 6.1% in 1Q as higher selling prices but also efficiency improvements over-compensated for higher recovered paper costs. We think this improvement once again underscores the companys track record when it comes to preserving/restoring profitability. Importantly, CEO Hörmanseder displayed confidence that profitability should remain >7% also in 2H (vs. 5.8% in 2H 16), suggesting a strongly positive earnings momentum. We understood that as of 3Q (Aug/Sep) the company has all selling price increases in the books, which heralds a stable price-cost differential (management does not anticipate a further uptick of prices for the time being owing to sufficient waste paper supply). Secondly, the company gave a more confident outlook, pointing towards a broad-based strengthening of order behaviour in its main European markets, which should not only preserve high capacity utilisation rates but also facilitate the passing on of input cost inflation. With regard to 2017 the management reiterated that the prior years record result represents a challenging level (do our best to match 2016). In the short run we regard a potential M&A transaction (pharma packaging) as the main catalyst for the share price. Although reiterating the commitment to external growth opportunities, the management was also vocal that price expectations are elevated (currently 10-11x EBITDA is demanded by sellers, whereas Mayr-Melnhof regards 8-8.5x as threshold), which hinders value-accretive transactions.
 
Fine-tuning of 2017e earnings estimates, no changes thereafter: We have tweaked our EBIT estimate for the current year to EUR 213 mn (flat yoy) from EUR 216 mn and thus EPS has come down to EUR 7.64 from EUR 7.73. The 2018-19e operating profit estimates of EUR 224 mn and EUR 233 mn, respectively, have remained unchanged.
 
Valuation: The total-return target price of EUR 123 (incl. DPS of EUR 3.10) is based on an equally weighted combination of economic profit (renders about EUR 114 based on the 2018e post-tax ROCE estimate of 11.2%) and DCF (suggests ca. EUR 126 based on a perpetual EBIT margin of 8.7% and TG of 1.5%) models. Compared to the peer group MMKs valuation appears compelling. In terms of 2017-18e P/Es the stock is valued in line, but offers a ca. 15% discount on EV/EBITDA multiples (6.9x and 6.4x vs. sector median of 8.1x and 7.5x) which widens to a range of 20-25% on EV/EBIT (10.2x and 9.4x vs. sector median of 13.1x and 11.5x).

Company im Artikel

Mayr-Melnhof

 
Mitglied in der BSN Peer-Group Zykliker Österreich
Show latest Report (19.08.2017)
 
Für Zusatzliquidität im Orderbuch der Mayr-Melnhof-Aktien sorgen die Raiffeisen Centrobank AG als Specialist sowie die Market Maker Erste Group Bank AG, Oddo Seydler Bank AG und Virtu Financial Ireland Limited, Klick auf Institut/Bank öffnet Übersicht.



Mayr-Melnhof © finanzmarktfoto.at/Martina Draper



Aktien auf dem Radar:VIG, Austriacard Holdings AG, Amag, Pierer Mobility, EuroTeleSites AG, Addiko Bank, ATX, ATX Prime, ATX TR, ATX NTR, DO&CO, Erste Group, Rosgix, EVN, voestalpine, Agrana, FACC, Frequentis, Kapsch TrafficCom, Palfinger, Semperit, BKS Bank Stamm, Oberbank AG Stamm, Mayr-Melnhof, AT&S, CPI Europe AG, Österreichische Post, RHI Magnesita, Telekom Austria, Hannover Rück, Nike.

(BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

Random Partner #goboersewien

Agrana
Die Agrana Beteiligungs-AG ist ein Nahrungsmittel-Konzern mit Sitz in Wien. Agrana erzeugt Zucker, Stärke, sogenannte Fruchtzubereitungen und Fruchtsaftkonzentrate sowie Bioethanol. Das Unternehmen veredelt landwirtschaftliche Rohstoffe zu vielseitigen industriellen Produkten und beliefert sowohl lokale Produzenten als auch internationale Konzerne, speziell die Nahrungsmittelindustrie.

>> Besuchen Sie 62 weitere Partner auf boerse-social.com/goboersewien

Meistgelesen
>> mehr





PIR-Zeichnungsprodukte
Newsflow
>> mehr

Börse Social Club Board
>> mehr
    BSN MA-Event Hannover Rück
    #gabb #2005

    Featured Partner Video

    Börsepeople im Podcast S22/14: Franz Tretter

    Franz Tretter ist CEO von hello again und davor hat er Szene1.at, das seinerzeit grösste Social Media Netzwerk in Österreich, aufgebaut. Wir sprechen lange über Szene1, über Fotos, Flirten, Matche...

    Books josefchladek.com

    Sasha & Cami Stone
    Femmes. Collection d'études photographiques du corps humain
    1933
    Arts et Métiers Graphiques

    Pieter Hugo
    The Hyena & Other Men
    2007
    Prestel

    Ció Prat i Bofill
    Milions d’estels i un somni
    2025
    Self published

    Paul Graham
    A1: The Great North Road
    1983
    Grey Editions

    Niko Havranek
    Fleisch #74 „Ganz Wien“
    2025
    Self published

    Inbox: RCB erhöht Mayr-Melnhof-Kursziel


    22.08.2017, 4765 Zeichen

    22.08.2017

    Zugemailt von / gefunden bei: RCB (BSN-Hinweis: Lauftext im Original des Aussenders, Titel (immer) und Bebilderung (oft) durch boerse-social.com aus dem Fotoarchiv von photaq.com)

    Mayr-Melnhof confirmed at BUY, TP EUR 123 - Cartonboard margin recovery confirmed

    - We maintain the BUY recommendation for Mayr-Melnhof on the back of a slight target price increase to EUR 123 from EUR 119
    - 2Q results were no catalyst, but we identify two positive take-aways: 1) The EBIT margin in the MM Karton division recouped the 7% threshold thanks to higher selling prices and 2) the company gave a more confident outlook, pointing towards a broad-based strengthening of order behaviour in its main European markets
    - In the short run we regard a potential M&A transaction (pharma packaging) as the main catalyst for the share price
    - We have tweaked our EBIT estimate for the current year to EUR 213 mn (flat yoy) from EUR 216 mn whereas 2018-19e operating profit estimates of EUR 224 mn and EUR 233 mn, respectively, have remained unchanged.

    We maintain the BUY recommendation for Mayr-Melnhof on the back of a slight target price increase to EUR 123 from EUR 119. 2Q results were no catalyst, with operating profit and EPS marginally shy of expectations, but we identify two positive take-aways. Firstly, the EBIT margin in the MM Karton division recouped the 7% threshold from 5.6% in 4Q and 6.1% in 1Q as higher selling prices but also efficiency improvements over-compensated for higher recovered paper costs. We think this improvement once again underscores the companys track record when it comes to preserving/restoring profitability. Importantly, CEO Hörmanseder displayed confidence that profitability should remain >7% also in 2H (vs. 5.8% in 2H 16), suggesting a strongly positive earnings momentum. We understood that as of 3Q (Aug/Sep) the company has all selling price increases in the books, which heralds a stable price-cost differential (management does not anticipate a further uptick of prices for the time being owing to sufficient waste paper supply). Secondly, the company gave a more confident outlook, pointing towards a broad-based strengthening of order behaviour in its main European markets, which should not only preserve high capacity utilisation rates but also facilitate the passing on of input cost inflation. With regard to 2017 the management reiterated that the prior years record result represents a challenging level (do our best to match 2016). In the short run we regard a potential M&A transaction (pharma packaging) as the main catalyst for the share price. Although reiterating the commitment to external growth opportunities, the management was also vocal that price expectations are elevated (currently 10-11x EBITDA is demanded by sellers, whereas Mayr-Melnhof regards 8-8.5x as threshold), which hinders value-accretive transactions.
     
    Fine-tuning of 2017e earnings estimates, no changes thereafter: We have tweaked our EBIT estimate for the current year to EUR 213 mn (flat yoy) from EUR 216 mn and thus EPS has come down to EUR 7.64 from EUR 7.73. The 2018-19e operating profit estimates of EUR 224 mn and EUR 233 mn, respectively, have remained unchanged.
     
    Valuation: The total-return target price of EUR 123 (incl. DPS of EUR 3.10) is based on an equally weighted combination of economic profit (renders about EUR 114 based on the 2018e post-tax ROCE estimate of 11.2%) and DCF (suggests ca. EUR 126 based on a perpetual EBIT margin of 8.7% and TG of 1.5%) models. Compared to the peer group MMKs valuation appears compelling. In terms of 2017-18e P/Es the stock is valued in line, but offers a ca. 15% discount on EV/EBITDA multiples (6.9x and 6.4x vs. sector median of 8.1x and 7.5x) which widens to a range of 20-25% on EV/EBIT (10.2x and 9.4x vs. sector median of 13.1x and 11.5x).

    Company im Artikel

    Mayr-Melnhof

     
    Mitglied in der BSN Peer-Group Zykliker Österreich
    Show latest Report (19.08.2017)
     
    Für Zusatzliquidität im Orderbuch der Mayr-Melnhof-Aktien sorgen die Raiffeisen Centrobank AG als Specialist sowie die Market Maker Erste Group Bank AG, Oddo Seydler Bank AG und Virtu Financial Ireland Limited, Klick auf Institut/Bank öffnet Übersicht.



    Mayr-Melnhof © finanzmarktfoto.at/Martina Draper





    BSN Podcasts
    Christian Drastil: Wiener Börse Plausch

    Wiener Börse Party #1059: ATX über 5200, Erste Group-Aktie mit Windenergie erstmals in der Dreistelligkeit, Opening Bell läutet Andrea Maier




    Mayr-Melnhof
    Akt. Indikation:  86.30 / 87.20
    Uhrzeit:  13:04:47
    Veränderung zu letztem SK:  0.29%
    Letzter SK:  86.50 ( 1.88%)



     

    Bildnachweis

    1. Mayr-Melnhof , (© finanzmarktfoto.at/Martina Draper)   >> Öffnen auf photaq.com

    Aktien auf dem Radar:VIG, Austriacard Holdings AG, Amag, Pierer Mobility, EuroTeleSites AG, Addiko Bank, ATX, ATX Prime, ATX TR, ATX NTR, DO&CO, Erste Group, Rosgix, EVN, voestalpine, Agrana, FACC, Frequentis, Kapsch TrafficCom, Palfinger, Semperit, BKS Bank Stamm, Oberbank AG Stamm, Mayr-Melnhof, AT&S, CPI Europe AG, Österreichische Post, RHI Magnesita, Telekom Austria, Hannover Rück, Nike.


    Random Partner

    Agrana
    Die Agrana Beteiligungs-AG ist ein Nahrungsmittel-Konzern mit Sitz in Wien. Agrana erzeugt Zucker, Stärke, sogenannte Fruchtzubereitungen und Fruchtsaftkonzentrate sowie Bioethanol. Das Unternehmen veredelt landwirtschaftliche Rohstoffe zu vielseitigen industriellen Produkten und beliefert sowohl lokale Produzenten als auch internationale Konzerne, speziell die Nahrungsmittelindustrie.

    >> Besuchen Sie 62 weitere Partner auf boerse-social.com/partner


    Mayr-Melnhof, (© finanzmarktfoto.at/Martina Draper)


    Useletter

    Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

    Newsletter abonnieren

    Runplugged

    Infos über neue Financial Literacy Audio Files für die Runplugged App
    (kostenfrei downloaden über http://runplugged.com/spreadit)

    per Newsletter erhalten


    Meistgelesen
    >> mehr





    PIR-Zeichnungsprodukte
    Newsflow
    >> mehr

    Börse Social Club Board
    >> mehr
      BSN MA-Event Hannover Rück
      #gabb #2005

      Featured Partner Video

      Börsepeople im Podcast S22/14: Franz Tretter

      Franz Tretter ist CEO von hello again und davor hat er Szene1.at, das seinerzeit grösste Social Media Netzwerk in Österreich, aufgebaut. Wir sprechen lange über Szene1, über Fotos, Flirten, Matche...

      Books josefchladek.com

      Daniele Torriglia
      Il senso della presenza
      2025
      Self published

      Jan Holkup
      Posedy / Hunting Stands
      2025
      PositiF

      Claudia Andujar
      Genocídio do Yanomami
      2025
      Void

      Wassili und Hans Luckhardt
      Zur neuen Wohnform
      1930
      Bauwelt-Verlag

      Paul Graham
      A1: The Great North Road
      1983
      Grey Editions